| RS104894086 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS104894087 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS104894089 |
STAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Syndactyly-telecanthus-anogenital and renal malformations syndrome |
| RS104894090 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS104894091 |
TNFRSF11B
|
Health Risk |
Pathogenic |
Hyperphosphatasemia with bone disease, Hyperphosphatasemia with bone disease |
| RS104894093 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS104894094 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma, cutaneous malignant |
| RS104894095 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Melanoma, cutaneous malignant |
| RS104894097 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS104894098 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma, cutaneous malignant |
| RS104894099 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Melanoma, cutaneous malignant |
| RS104894100 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS104894101 |
AK1
|
Health Risk |
Pathogenic |
Hemolytic anemia due to adenylate kinase deficiency, Hemolytic anemia due to adenylate kinase deficiency |
| RS104894102 |
AK1
|
Health Risk |
Likely pathogenic |
Hemolytic anemia due to adenylate kinase deficiency, Hemolytic anemia due to adenylate kinase deficiency |
| RS104894103 |
APTX
|
Health Risk |
Pathogenic |
Ataxia, early-onset |
| RS104894105 |
FXN
|
Health Risk |
Pathogenic |
Friedreich ataxia, Friedreich ataxia |
| RS104894106 |
FXN
|
Health Risk |
Pathogenic |
Friedreich ataxia, Friedreich ataxia 1 |
| RS104894107 |
FXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Friedreich ataxia, Friedreich ataxia 1 |
| RS104894108 |
FXN
|
Health Risk |
Pathogenic |
Friedreich ataxia, Friedreich ataxia 1 |
| RS104894109 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Melanoma, cutaneous malignant |
| RS104894110 |
FOXE1
|
Health Risk |
Pathogenic |
Bamforth-Lazarus syndrome, Bamforth-Lazarus syndrome |
| RS104894111 |
FOXE1
|
Health Risk |
Pathogenic |
Bamforth-Lazarus syndrome, Bamforth-Lazarus syndrome |
| RS104894113 |
KCNV2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone dystrophy with supernormal rod response, KCNV2-related disorder |
| RS104894117 |
LHX3
|
Health Risk |
Pathogenic |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS104894119 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS104894120 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS104894121 |
ROR2
|
Health Risk |
Pathogenic |
Brachydactyly type B1, Brachydactyly type B1 |
| RS104894122 |
ROR2
|
Health Risk |
Pathogenic |
Brachydactyly type B1, Brachydactyly type B1 |
| RS104894123 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS104894124 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS104894125 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS104894126 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS104894127 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS104894129 |
TPM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy 23, Arthrogryposis |
| RS104894130 |
TYRP1
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 3, ALBINISM |
| RS104894131 |
XPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS104894132 |
XPA
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS104894133 |
XPA
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS104894134 |
XPA
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS104894135 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894136 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894137 |
CYP17A1
|
Health Risk |
Likely pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894138 |
CYP17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894139 |
CYP17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
17, 20-lyase deficiency |
| RS104894141 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894142 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894143 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894144 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894145 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894146 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894147 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894148 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894149 |
CYP17A1
|
Health Risk |
Likely pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894151 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894152 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894153 |
CYP17A1
|
Health Risk |
Likely pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894154 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894155 |
CYP17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS104894158 |
EGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1D |
| RS104894159 |
EGR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1D, Charcot-Marie-Tooth disease |
| RS104894161 |
EGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dejerine-sottas neuropathy, autosomal dominant |
| RS104894162 |
GATA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoparathyroidism, deafness |
| RS104894163 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS104894164 |
GATA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypoparathyroidism, deafness |
| RS104894165 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS104894166 |
LGI1
|
Health Risk |
Pathogenic |
Epilepsy, familial temporal lobe |
| RS104894167 |
LGI1
|
Health Risk |
Pathogenic |
Epilepsy, familial temporal lobe |
| RS104894169 |
NODAL
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotaxy, visceral |
| RS104894170 |
PAX2
|
Health Risk |
Likely pathogenic |
Papillorenal syndrome with macular abnormalities, Focal segmental glomerulosclerosis 7 |
| RS104894171 |
MINPP1
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS104894172 |
PCBD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS104894173 |
PHYH
|
Health Risk |
Likely pathogenic |
REFSUM DISEASE, ADULT |
| RS104894174 |
PHYH
|
Health Risk |
Pathogenic/Likely pathogenic |
REFSUM DISEASE, ADULT |
| RS104894175 |
PITX3
|
Health Risk |
Likely pathogenic |
Cataract 11 multiple types, Cataract 11 multiple types |
| RS104894176 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Autoinflammatory syndrome |
| RS104894177 |
PCBD1
|
Health Risk |
Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS104894178 |
PHYH
|
Health Risk |
Pathogenic/Likely pathogenic |
REFSUM DISEASE, ADULT |
| RS104894179 |
PHYH
|
Health Risk |
Pathogenic |
REFSUM DISEASE, ADULT |
| RS104894180 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS104894182 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS104894183 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS104894186 |
PTF1A
|
Health Risk |
Pathogenic |
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome, Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome |
| RS104894187 |
RGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 44, Cone dystrophy |
| RS104894188 |
RPS24
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 3, Diamond-Blackfan anemia 3 |
| RS104894189 |
RPS24
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 3, Diamond-Blackfan anemia |
| RS104894190 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary dependent hypercortisolism, Somatotroph adenoma |
| RS104894191 |
ALX4
|
Health Risk |
Pathogenic |
Parietal foramina 2, Parietal foramina 2 |
| RS104894192 |
ALX4
|
Health Risk |
Pathogenic |
Parietal foramina 2, Parietal foramina 2 |
| RS104894193 |
ALX4
|
Health Risk |
Pathogenic |
Parietal foramina 2, Parietal foramina 2 |
| RS104894194 |
AIP
|
Health Risk |
Pathogenic |
Pituitary adenoma predisposition, Somatotroph adenoma |
| RS104894195 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS104894196 |
ALX4
|
Health Risk |
Pathogenic |
Parietal foramina 2, Parietal foramina 2 |
| RS104894197 |
ALX4
|
Health Risk |
Pathogenic |
Parietal foramina 2, Parietal foramina 2 |
| RS104894198 |
CLCF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 2, Cold-induced sweating syndrome 2 |
| RS104894199 |
CD3G
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS104894200 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS104894201 |
CRYAB
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 2, Myofibrillar myopathy 2 |
| RS104894203 |
CLCF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 2, Cold-induced sweating syndrome 2 |
| RS104894204 |
CSRP3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 12, Cardiovascular phenotype |
| RS104894205 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 12, Dilated cardiomyopathy 1M |